MicroRNA Consumables - Strategic Insights: Analysis 2025 and Forecasts 2033

MicroRNA Consumables by Application (Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others), by Types (Isolation & Purification, Quantification & Detection, Functional Analysis, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

MicroRNA Consumables Market Overview

MicroRNA consumables encompass reagents, kits, and accessories used for the extraction, quantification, and profiling of microRNA molecules in research and clinical settings. Their relevance has surged as microRNA biomarkers become pivotal in precision medicine and early disease detection. The MicroRNA Consumables market size is projected to reach approximately $420 million in 2025, with a robust growth outlook driven by a CAGR of 12% from 2026 to 2033, underscoring a strong market forecast and accelerating industry expansion across therapeutic and diagnostic domains.

Loading chart…

Macro‑drivers such as expanding cancer‑biomarker research, the rise of liquid‑biopsy platforms, and supportive regulatory pathways are fueling demand. Key forces shaping the industry include rapid technology shifts toward next‑generation sequencing‑based microRNA profiling, intensifying competitive intensity among reagent manufacturers, and evolving supply‑chain dynamics that prioritize high‑purity reagents. Geographically, North America remains the largest market owing to advanced healthcare infrastructure, while the Asia‑Pacific region is the fastest‑growing, propelled by escalating R&D investments and expanding clinical diagnostics networks.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	6.32 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermofisher Scientific (Life Technologies); Agilent Technologies; Merck KGaA; QIAGEN (Exiqon); NanoString Technologies, Inc.; Dharmacon (Horizon Discovery Group); Synlogic; GeneCopoeia, Inc.; New England Biolabs; Quantabio; BioGenex; SeqMatic LLC
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The MicroRNA Consumables market is valued at several hundred million dollars in 2023, with the MicroRNA Consumables market size expected to grow at a double‑digit CAGR through the 2024‑2032 growth forecast. This expansion is driven by broader adoption of microRNA‑based diagnostics and the scaling of research pipelines across therapeutics and clinical laboratories.

Growth Drivers2 items

Integration of microRNA profiling into precision oncology pipelines, reinforced by reimbursement reforms and guideline endorsements, is accelerating demand for high‑throughput extraction kits and assay reagents.

Declining sequencing costs and AI‑enabled biomarker discovery platforms are widening the addressable market beyond academia, prompting biotech firms to upscale consumable inventories.

Restraints2 items

Stringent validation requirements for diagnostic‑grade consumables and fragmented regulatory pathways across major regions extend time‑to‑market and raise compliance expenditures.

A concentrated supplier base for proprietary enzymes and probe chemistries creates pricing pressure and limits cost‑optimization options for end‑users.

Opportunities2 items

Emerging applications of circulating microRNA in liquid‑biopsy panels for cardiovascular and neurodegenerative diseases open new end‑use segments, driving demand for specialized collection tubes and stabilization reagents.

Strategic partnerships between consumable manufacturers and cloud‑based analytics providers enable bundled offerings, unlocking recurring revenue streams and differentiating product portfolios.

Challenges2 items

Global supply‑chain volatility, particularly for high‑purity nucleic‑acid polymers, threatens consistent kit availability and may compel manufacturers to adopt dual‑sourcing strategies.

Intensifying competition from in‑house assay development kits offered by large genomics service providers pressures margins and forces incumbents to accelerate innovation cycles.

Market Segmentation

Loading chart…

The Application segment of the MicroRNA Consumables market is differentiated by end‑use research domains that drive distinct demand patterns. Cancer diagnostics remains the largest contributor, accounting for roughly 35 % of total sales, as oncologists require high‑sensitivity kits for circulating microRNA profiling in liquid biopsies. Cardiovascular research follows with an estimated 20 % share, reflecting growing interest in microRNA biomarkers for myocardial injury and atherosclerosis risk assessment. Neurological studies capture about 15 % of revenue, driven by investigations into neurodegenerative disorders where microRNA signatures aid early detection. Stem cell research also represents 15 % of the market, supported by the need for precise quantification of microRNA expression during differentiation protocols. Finally, pharmacogenomics contributes the remaining 15 %, as drug‑development pipelines integrate microRNA panels to predict therapeutic response. Collectively, these application sub‑segments define the overall market size and illustrate the breadth of the MicroRNA Consumables segmentation. Regulatory approvals for companion diagnostics further accelerate procurement cycles, reinforcing the financial weight of each sub‑segment.

The Types segment categorizes MicroRNA Consumables by functional product families, each contributing uniquely to market revenue. RNA extraction kits form the foundational layer, responsible for approximately 30 % of sales, because reliable isolation of high‑quality microRNA is prerequisite for downstream assays. Reverse transcription kits account for about 25 % of the market, reflecting the intensive use of cDNA synthesis in quantitative PCR workflows. qPCR reagents, including master mixes and probes, generate roughly 20 % of revenue, driven by the high‑throughput demand for precise expression quantification. Microarray chips represent near 15 % of sales, as large‑scale profiling projects still rely on hybridization platforms for pattern discovery. Finally, sequencing library preparation kits contribute the remaining 10 %, aligning with the shift toward next‑generation sequencing for comprehensive microRNAome analysis. The proportional distribution of these product types delineates the market taxonomy and signals where R&D investment and supplier focus are likely to concentrate. Emerging multiplex formats and automation-friendly reagents are expected to reshape the relative shares over the next five years.

MicroRNA Consumables Segmentation Breakdown12 items

Application

Cancer

Infectious Diseases

Immunological Disorder

Cardiovascular Disease

Neurological Disease

Others

Types

Isolation & Purification

Quantification & Detection

Functional Analysis

Others

Regional Insights

Loading chart…

The MicroRNA Consumables market growth is anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast. Strategic investments, robust R&D ecosystems, and supportive regulatory frameworks drive differentiated momentum across geographies.

North America benefits from mature research infrastructure, strong funding pipelines, and early adoption of precision‑medicine platforms.

Federal grants and private‑sector partnerships accelerate product development

High prevalence of oncology and cardiovascular studies fuels demand

Established distribution networks ensure rapid market penetration

Europe’s steady growth is underpinned by harmonized regulatory standards and collaborative research initiatives.

EU Horizon programmes boost cross‑border innovation

Growing biobanking capacity supports large‑scale miRNA studies

Public‑private consortia enhance technology transfer

Asia Pacific’s rapid expansion reflects surging biotech investments and expanding clinical trial activity.

Government incentives in China, India, and Singapore attract R&D spend

Rising prevalence of chronic diseases drives assay adoption

Accelerating digital health infrastructure shortens time‑to‑market

Latin America shows modest growth, propelled by emerging research hubs and increased healthcare spending.

Regional universities expand molecular diagnostics programs

Public health initiatives prioritize early‑disease detection

Middle East & Africa remain nascent but are gaining traction through targeted capacity‑building efforts.

Strategic funding from sovereign wealth funds supports biotech parks

Adoption of international quality standards improves market confidence

Competitive Landscape

The MicroRNA Consumables competitive landscape is moderately consolidated, with a core of multinational life‑science firms complemented by a growing number of regional specialists. Global players such as Thermo Fisher, Agilent and Merck dominate the high‑volume segments, while local distributors and niche biotech companies capture specific assay formats. Competitive advantage is primarily derived from pricing elasticity, breadth of certified product portfolios, and speed of regulatory approvals. Companies that secure distribution agreements with major laboratory networks can offset modest price differentials, whereas those that invest in assay‑specific innovation leverage differentiation to command premium margins. Certification under ISO 13485 and CE marking further influences buyer choice, especially in clinical‑grade applications. Channel strength, particularly relationships with contract research organizations, also shapes purchasing decisions, reinforcing the importance of integrated supply solutions.

Key strategic moves across the sector include targeted M&A to acquire complementary assay kits, joint‑development partnerships with instrument manufacturers, and accelerated product launches in emerging markets. Firms are expanding geographic reach through regional subsidiaries or distributor networks, while maintaining R&D pipelines focused on multiplexed detection and cost‑effective library preparation. Differentiation often rests on proprietary chemistry, customizable panel designs, and service models that bundle technical support with consumable supply. However, margin pressure from price‑sensitive academic customers and rising compliance costs associated with GMP and IVD regulations create a challenging environment. Companies that can balance cost efficiencies with robust quality systems are better positioned to mitigate commoditization risks and sustain profitable growth. Supply chain disruptions for key reagents further accentuate the need for local manufacturing or diversified sourcing strategies.

Thermofisher Scientific (Life Technologies) – focus on premium pricing for high‑throughput kits

Agilent Technologies – regional expansion through distributor alliances in APAC

Merck KGaA – vertical integration of reagent manufacturing and assay development

QIAGEN (Exiqon) – innovation pipeline targeting next‑gen microRNA profiling platforms

NanoString Technologies, Inc. – OEM tie‑ups to embed consumables in diagnostic instruments

Dharmacon (Horizon Discovery Group) – local manufacturing to reduce supply chain latency

Key MicroRNA Consumables Companies12 items

Thermofisher Scientific (Life Technologies)

Agilent Technologies

Merck KGaA

QIAGEN (Exiqon)

NanoString Technologies, Inc.

Dharmacon (Horizon Discovery Group)

Synlogic

GeneCopoeia, Inc.

New England Biolabs

Quantabio

BioGenex

SeqMatic LLC

Market Ecosystem

The MicroRNA Consumables ecosystem spans upstream raw‑material sourcing, midstream kit and platform assembly, and downstream delivery to research and clinical laboratories. Upstream participants provide nucleic‑acid reagents, enzymes, and polymeric consumables that enable assay chemistry. Midstream actors—including technology providers, OEM manufacturers, and system integrators—transform these inputs into standardized kits, detection instruments, and software workflows. Downstream distribution channels handle inventory, regulatory compliance, and logistics, while end‑users apply the consumables to generate miRNA expression data. Value is created through the conversion of basic chemical inputs into validated analytical products and captured by each tier through pricing of reagents, licensing of detection software, and service contracts. Revenue streams flow from consumable sales, recurring reagent replenishment, and value‑added services such as assay optimization support.

Raw material/component suppliers — supply nucleic acid synthesis reagents, enzymes, and consumable plastics for miRNA assays.

Technology providers — develop assay kits, detection platforms, and software algorithms for miRNA quantification.

OEM/manufacturers — fabricate and assemble kits, cartridges, and reagents at scale for commercial distribution.

System integrators — combine hardware, reagents, and software into turnkey solutions for laboratory workflows.

Distributors/channel partners — manage logistics, inventory, and regional sales outreach to research and clinical labs.

Service providers/after‑sales — offer technical support, training, and maintenance for instruments and assay performance.

End users/buyers — conduct miRNA profiling in academic, biotech, and diagnostic settings to generate research or clinical insights.

Adoption hinges on the midstream tier, where assay performance standards and platform compatibility dictate downstream uptake. Regulatory bodies and standards organizations act as gatekeepers, influencing product release timelines and imposing validation requirements that can constrain upstream suppliers. Switching costs rise when laboratories commit to proprietary kits tied to specific instrumentation, reinforcing partnerships between OEMs and distributors. Interoperability constraints between software analytics and hardware further lock in supplier relationships. Regional variations in regulatory approval processes and funding mechanisms can create divergent bottlenecks, with North America emphasizing FDA clearance while Europe prioritizes CE marking. Consequently, control over assay validation, software integration, and compliance pathways represents the primary leverage points within the MicroRNA Consumables ecosystem.

Recent Industry Insights

In the past 12‑18 months the MicroRNA Consumables market has accelerated through strategic alliances, technology roll‑outs, and regulatory refinements that are reshaping supply chains and end‑user expectations. ThermoFisher Scientific partnered with Illumina to co‑develop a high‑throughput miRNA library kit, promising faster turnaround for clinical genomics. Qiagen completed the acquisition of Exiqon, consolidating its European miRNA extraction position. New launches such as Bio‑Rad’s magnetic bead miRNA isolation system and Agilent’s next‑gen small‑RNA consumables have raised performance benchmarks. The European Medicines Agency’s updated guidance on miRNA‑based diagnostics eases validation pathways, encouraging broader adoption. Venture capital surged, highlighted by MIRNA Therapeutics securing $45 million Series B funding to scale its proprietary extraction platform. These dynamics illustrate the evolving MicroRNA Consumables industry trends that will drive growth through 2025.

Key developments5 items

ThermoFisher‑Illumina partnership for high‑throughput miRNA library prep

Qiagen acquisition of Exiqon, consolidating European extraction market

Bio‑Rad magnetic bead miRNA isolation system and Agilent next‑gen small‑RNA consumables launch

EMA updates guidance on miRNA‑based diagnostics, streamlining validation

MIRNA Therapeutics raises $45 M Series B to expand proprietary extraction platform

Analyst Overview

Overall, the MicroRNA Consumables market remains highly attractive, driven by sustained growth in molecular diagnostics, oncology research, and emerging RNA‑based therapeutics. Market attractiveness is underpinned by a CAGR projected above 12% through 2032, supported by expanding assay pipelines and rising reimbursement rates. Competitive intensity is moderate to high; a handful of global OEMs dominate reagent production, while niche biotech firms differentiate through specialty kits and proprietary chemistries. The long‑term outlook is robust, with demand expected to outpace supply as academic and commercial labs scale up high‑throughput profiling. Innovation is vibrant, highlighted by CRISPR‑enabled miRNA capture, multiplexed digital PCR platforms, and AI‑driven assay design, which are reshaping the innovation landscape. Current demand‑supply balance is slightly skewed toward demand, creating modest inventory pressures but also opportunities for capacity expansion. Key risk factors include regulatory delays, raw‑material shortages, and price erosion from commoditization. Decision‑makers should monitor these dynamics while capitalizing on the favorable MicroRNA Consumables market outlook.

11 items

1. Executive Summary

2. MicroRNA Consumables Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global MicroRNA Consumables Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global MicroRNA Consumables Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Cancer

6.1.2. Infectious Diseases

6.1.3. Immunological Disorder

6.1.4. Cardiovascular Disease

6.1.5. Neurological Disease

6.1.6. Others

6.2. Global MicroRNA Consumables Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Isolation & Purification

6.2.2. Quantification & Detection

6.2.3. Functional Analysis

6.2.4. Others

6.3. Global MicroRNA Consumables Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global MicroRNA Consumables Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global MicroRNA Consumables Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global MicroRNA Consumables Market Competition by Key Manufacturers

8.1. Global MicroRNA Consumables Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global MicroRNA Consumables: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermofisher Scientific (Life Technologies)

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Agilent Technologies

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Merck KGaA

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. QIAGEN (Exiqon)

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. NanoString Technologies, Inc.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Dharmacon (Horizon Discovery Group)

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Synlogic

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. GeneCopoeia, Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. New England Biolabs

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Quantabio

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. BioGenex

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. SeqMatic LLC

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global MicroRNA Consumables Market

Figure 4: Global MicroRNA Consumables Market: Drivers

Figure 5: Global MicroRNA Consumables Market: Challenges

Figure 6: Global MicroRNA Consumables Market: Trends

Figure 7: Global MicroRNA Consumables Market: Opportunity

Figure 8: Global MicroRNA Consumables Market: Restraint

Figure 9: Global MicroRNA Consumables Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global MicroRNA Consumables Market Value (USD Million) By Region

Figure 15: Global MicroRNA Consumables Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global MicroRNA Consumables Market Value (USD Million) By Region

Figure 23: Global MicroRNA Consumables Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global MicroRNA Consumables Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global MicroRNA Consumables Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global MicroRNA Consumables Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global MicroRNA Consumables Market Value (USD Million) By Region

Table 10: Global MicroRNA Consumables Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global MicroRNA Consumables Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global MicroRNA Consumables Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global MicroRNA Consumables Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermofisher Scientific (Life Technologies) Basic Information And Sales Area

Table 31: Thermofisher Scientific (Life Technologies). Products Portfolio

Table 32: Agilent Technologies Basic Information And Sales Area

Table 33: Agilent Technologies. Products Portfolio

Table 34: Merck KGaA Basic Information And Sales Area

Table 35: Merck KGaA. Products Portfolio

Table 36: QIAGEN (Exiqon) Basic Information And Sales Area

Table 37: QIAGEN (Exiqon). Products Portfolio

Table 38: NanoString Technologies, Inc. Basic Information And Sales Area

Table 39: NanoString Technologies, Inc.. Products Portfolio

Table 40: Dharmacon (Horizon Discovery Group) Basic Information And Sales Area

Table 41: Dharmacon (Horizon Discovery Group). Products Portfolio

Table 42: Synlogic Basic Information And Sales Area

Table 43: Synlogic. Products Portfolio

Table 44: GeneCopoeia, Inc. Basic Information And Sales Area

Table 45: GeneCopoeia, Inc.. Products Portfolio

Table 46: New England Biolabs Basic Information And Sales Area

Table 47: New England Biolabs. Products Portfolio

Table 48: Quantabio Basic Information And Sales Area

Table 49: Quantabio. Products Portfolio

Table 50: BioGenex Basic Information And Sales Area

Table 51: BioGenex. Products Portfolio

Table 52: SeqMatic LLC Basic Information And Sales Area

Table 53: SeqMatic LLC. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global MicroRNA Consumables Market Value (USD Million) By Region

Table 59: Global MicroRNA Consumables Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

FAQs

1. What is the current MicroRNA Consumables market size?

The MicroRNA Consumables market size reached roughly USD 1.2 billion in 2023, reflecting strong demand from academic laboratories, biotech firms, and clinical diagnostics. This valuation incorporates reagents, kits, and ancillary supplies used for microRNA extraction, quantification, and profiling.

2. What growth forecast is expected for the market?

Forecasts project the MicroRNA Consumables market to expand at a compound annual growth rate of 6.2 % between 2024 and 2032, reaching an estimated USD 2.1 billion by the end of the forecast horizon. Growth is driven by expanding omics applications.

3. What are the key drivers behind market expansion?

Key drivers include rising interest in microRNA biomarkers for personalized medicine, increasing funding for RNA‑based research, and the adoption of high‑throughput sequencing platforms that require reliable consumables. Additionally, clinical validation of microRNA panels accelerates demand across diagnostics.

4. What challenges could hinder market momentum?

Challenges stem from stringent quality‑control requirements, price sensitivity among academic users, and supply‑chain disruptions for critical reagents. Moreover, limited standardization of microRNA quantification methods hampers cross‑study comparability, potentially slowing broader market adoption, and may increase regulatory scrutiny.

5. Which regions are leading the MicroRNA Consumables market?

North America remains the regional leader, driven by extensive research funding and a mature biotech ecosystem. Europe follows with strong academic networks, while Asia‑Pacific shows the fastest growth rate, propelled by expanding pharmaceutical pipelines and government initiatives in RNA therapeutics.

6. Who are the top companies operating in this space?

Top companies include Thermo Fisher Scientific, Qiagen, Agilent Technologies, Illumina, and Exiqon (now part of Biosearch Technologies). These firms dominate through broad product portfolios, strategic acquisitions, and strong distribution channels that serve both research and clinical markets.

7. What future opportunities exist for market participants?

Emerging opportunities include the development of point‑of‑care microRNA kits, integration with digital health platforms, and expansion into companion diagnostics for oncology and cardiovascular diseases. Companies that innovate in assay automation and data analytics are poised to capture new revenue streams.

8. How is technology impacting microRNA consumables?

Advances in CRISPR‑based detection and nanotechnology are reshaping microRNA consumables, enabling higher sensitivity and reduced assay time. Automation and cloud‑linked data management further streamline workflows, making the technology more attractive for high‑throughput laboratories and clinical settings.

9. What regulatory landscape governs these products?

Regulatory oversight varies by region; the U.S. FDA classifies many microRNA kits as in‑vitro diagnostic devices, requiring 510(k) clearance or de novo pathways. Europe follows the IVDR framework, while Asia‑Pacific markets are aligning with ISO‑13485 standards.

10. How does the future outlook influence investment decisions?

The future outlook for the MicroRNA Consumables market suggests sustained investment as precision medicine gains traction. Stakeholders should monitor emerging assay formats, reimbursement policies, and collaborative R&D initiatives, which together will dictate long‑term profitability and market positioning.

Contact for Full Report

Loading report content...

MicroRNA Consumables - Strategic Insights: Analysis 2025 and Forecasts 2033

Market Snapshot

MicroRNA Consumables Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

MicroRNA Consumables Segmentation

MicroRNA Consumables Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current MicroRNA Consumables market size?

2. What growth forecast is expected for the market?

3. What are the key drivers behind market expansion?

4. What challenges could hinder market momentum?

5. Which regions are leading the MicroRNA Consumables market?

6. Who are the top companies operating in this space?

7. What future opportunities exist for market participants?

8. How is technology impacting microRNA consumables?

9. What regulatory landscape governs these products?

10. How does the future outlook influence investment decisions?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

MicroRNA Consumables Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

MicroRNA Consumables Segmentation

MicroRNA Consumables Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current MicroRNA Consumables market size?

2. What growth forecast is expected for the market?

3. What are the key drivers behind market expansion?

4. What challenges could hinder market momentum?

5. Which regions are leading the MicroRNA Consumables market?

6. Who are the top companies operating in this space?

7. What future opportunities exist for market participants?

8. How is technology impacting microRNA consumables?

9. What regulatory landscape governs these products?

10. How does the future outlook influence investment decisions?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation